Sun, Dec 28, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Hedge funds down in January, still outperform - Citi Prime Finance

Monday, March 03, 2014

Bailey McCann, Opalesque New York:

New hedge fund data from Citi Prime Finance shows that hedge funds were down slightly through January but still outperformed the index. January volatility from weakness in emerging markets and US economic data contributed to the drag on performance. Composite hedge fund performance, equal-weighted across funds, was down in January 2014 with performance ranging from -0.24% to +0.54%. Returns were lower than the previous month which experienced +0.56% to +1.1% over the same period.

In terms of specific strategies, top performing strategies in January 2014 include Dedicated Short at +2.01%, Distressed +1.20%, Fixed Income Arbitrage +0.62%, and Convertible Arbitrage at +0.57. The lowest performing strategies include Emerging Markets -2.66%, Global Macro -0.81%, and Equity Long/ Short at -0.63%.

According to eVestment|HFN, Hedge fund industry assets fell in January 2014 -$14.2 billion for the month after experiencing +22.6 billion in growth in December. January losses were attributed solely from performance which totaled -$14.5 billion. For the month, investors flows were net positive, however only accounted for +$0.3 billion of net new flows.

Net positive investor flows of +$0.3 billion for January 2014 marks the first period of positive flows since November 2013. January flows were lower than the mean monthly flows for 2013 which stood at +$5.6 billion. January 2013 net flows were +$3.3 billion over the same period.

L......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its